Cartesian Therapeutics Management
Management criteria checks 1/4
Cartesian Therapeutics' CEO is Carsten Brunn, appointed in Dec 2018, has a tenure of 5.75 years. total yearly compensation is $6.11M, comprised of 10.1% salary and 89.9% bonuses, including company stock and options. directly owns 0.037% of the company’s shares, worth $148.42K. The average tenure of the management team and the board of directors is 0.8 years and 4.8 years respectively.
Key information
Carsten Brunn
Chief executive officer
US$6.1m
Total compensation
| CEO salary percentage | 10.1% |
| CEO tenure | 5.8yrs |
| CEO ownership | 0.04% |
| Management average tenure | less than a year |
| Board average tenure | 4.8yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$267m |
| Mar 31 2024 | n/a | n/a | -US$288m |
| Dec 31 2023 | US$6m | US$618k | -US$257m |
Compensation vs Market: Carsten's total compensation ($USD6.11M) is above average for companies of similar size in the US market ($USD2.40M).
Compensation vs Earnings: Insufficient data to compare Carsten's compensation with company performance.
CEO
Carsten Brunn (53 yo)
5.8yrs
Tenure
US$6,111,883
Compensation
Dr. Carsten Brunn, Ph.D. serves as President, Chief Executive Officer & Director of Cartesian Therapeutics, Inc. since December 2018. He served as an Independent Director at Surface Oncology, Inc. since Ju...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.8yrs | US$6.11m | 0.037% $ 148.4k | |
| Chief Financial Officer | 1.8yrs | US$2.49m | no data | |
| Chief Technology Officer | less than a year | US$398.28k | 0% $ 0 | |
| Chief Scientific Officer | less than a year | US$296.85k | 0% $ 0 | |
| General Counsel & Secretary | no data | no data | no data | |
| Chief Medical Officer | less than a year | no data | 0% $ 0 | |
| SVP & Head of Manufacturing | less than a year | no data | 0% $ 0 | |
| Senior Director of Technology | no data | no data | no data |
0.8yrs
Average Tenure
44.5yo
Average Age
Experienced Management: RNAC's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.8yrs | US$6.11m | 0.037% $ 148.4k | |
| Independent Chairman of the Board | 4.8yrs | US$292.32k | 0.030% $ 120.6k | |
| Independent Director | 8.2yrs | US$212.93k | 0.066% $ 269.1k | |
| Independent Director | 7.3yrs | US$192.05k | 0.0077% $ 31.3k | |
| Director | 8.3yrs | US$192.73k | 36.3% $ 147.4m | |
| Independent Director | 3.3yrs | US$188.58k | 0.00098% $ 4.0k | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | less than a year | US$5.37k | 2.09% $ 8.5m | |
| Independent Director | less than a year | US$5.71k | 1.28% $ 5.2m |
4.8yrs
Average Tenure
62yo
Average Age
Experienced Board: RNAC's board of directors are considered experienced (4.8 years average tenure).